Get the Stockscreener App
1.76
3.30%
-0.06
After Hours:
1.76
Nuvation Bio Inc stock is traded at $1.76, with a volume of 3.05M.
It is down -3.30% in the last 24 hours and down -10.66% over the past month.
See More
Previous Close:
$1.82
Open:
$1.79
24h Volume:
3.05M
Relative Volume:
1.26
Market Cap:
$633.33M
Revenue:
-
Net Income/Loss:
$-75.80M
P/E Ratio:
-5.0286
EPS:
-0.35
Net Cash Flow:
$-68.07M
1W Performance:
-10.20%
1M Performance:
-10.66%
6M Performance:
-23.14%
1Y Performance:
-51.65%
1-Day Range:
$1.695
$1.79
1-Week Range:
$1.695
$2.04
52-Week Range:
$1.695
$3.97
Nuvation Bio Inc Stock (NUVB) Company Profile
Name
Nuvation Bio Inc
Sector
Industry
Phone
(415) 754-3517
Address
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
Compare NUVB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
1.76 | 633.33M | 0 | -75.80M | -68.07M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-27-24 | Upgrade | Jefferies | Hold → Buy |
| Mar-26-24 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-06-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-02-22 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Aug-02-22 | Downgrade | BTIG Research | Buy → Neutral |
| May-04-22 | Initiated | H.C. Wainwright | Buy |
| Oct-15-21 | Resumed | BTIG Research | Buy |
| Apr-06-21 | Initiated | RBC Capital Mkts | Outperform |
| Mar-08-21 | Initiated | BMO Capital Markets | Outperform |
| Mar-08-21 | Initiated | BTIG Research | Buy |
| Mar-08-21 | Initiated | Cowen | Outperform |
| Mar-08-21 | Initiated | Jefferies | Buy |
| Mar-08-21 | Initiated | Wedbush | Outperform |
View All
Nuvation Bio Inc Stock (NUVB) Latest News
Nuvation Bio stock hits 52-week low at $1.7 amid market challenges - Investing.com India
Swiss National Bank Buys 136,600 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Wedbush Reaffirms “Outperform” Rating for Nuvation Bio (NYSE:NUVB) - Defense World
Nuvation Bio Inc (NYSE: NUVB) Has Great Upside Potential - Stocks Register
Nuvation Bio Inc. (NYSE:NUVB) Stock Position Boosted by Charles Schwab Investment Management Inc. - Defense World
Nuvation Bio to Present New Nonclinical Data for Taletrectinib at the American Association for Cancer Research Annual Meeting 2025 - BioSpace
Breakthrough Cancer Drug Data: How Taletrectinib Targets Resistant Lung Cancer - Stock Titan
Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Crizotinib During Mini Oral Presentation at the European Lung Cancer Congress 2025 - BioSpace
Nuvation Bio Enters Supply Agreement With Asymchem For Taletrectinib - Marketscreener.com
Insider Stock Buying Reaches US$720.1k On Nuvation Bio - Yahoo Finance
Breakthrough Lung Cancer Treatment Comparison: Taletrectinib Shows Head-to-Head Data vs Standard Therapy - Stock Titan
Bank of New York Mellon Corp Buys 14,203 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Sees Unusually High Options Volume (NYSE:NUVB) - Defense World
Nuvation Bio Inc (NYSE: NUVB) Is The Number One Stock Currently Moving. - Stocks Register
Is Nuvation Bio Inc. (NYSE:NUVB) the Most Oversold Penny Stocks to Buy According to Analysts? - Insider Monkey
Arizona State Retirement System Grows Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
10 Most Oversold Penny Stocks to Buy According to Analysts - Insider Monkey
Analysts Set Nuvation Bio Inc. (NYSE:NUVB) Target Price at $8.33 - Defense World
Nuvation Bio Inc (NUVB): Be Patient, You Will Learn - Stocks Register
Jones Trading Begins Coverage on Nuvation Bio (NYSE:NUVB) - Defense World
Q1 EPS Estimates for Nuvation Bio Decreased by HC Wainwright - Defense World
Jones Trading Initiates Coverage of Nuvation Bio (NUVB) with Buy Recommendation - Nasdaq
Nuvation Bio Positioned for Growth with Key Therapeutics and Strategic Leadership - TipRanks
Jones Trading sets $10 target for Nuvation Bio stock with Buy rating - Investing.com Australia
Jones Trading sets $10 target for Nuvation Bio stock with Buy rating By Investing.com - Investing.com South Africa
Nuvation Bio initiated with a Buy at JonesResearch - TipRanks
Nuvation Bio (NYSE:NUVB) Shares Gap Down Following Analyst Downgrade - Defense World
Nuvation Bio (NYSE:NUVB) Price Target Cut to $10.00 by Analysts at HC Wainwright - Defense World
Nuvation Bio stock price target cut to $10 by H.C. Wainwright - Investing.com Canada
Nuvation Bio (NYSE:NUVB) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
Nuvation Bio Inc (NUVB) expanding its growth trajectory ahead - SETE News
Q1 Earnings Estimate for Nuvation Bio Issued By Wedbush - Defense World
Nuvation Bio Inc. (NUVB): Among the Best NYSE Penny Stocks to Buy According to Analysts - Insider Monkey
Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact L - GuruFocus.com
Nuvation Bio Reports Transformative Year in 2024 - TipRanks
12 Best NYSE Penny Stocks to Buy According to Analysts - Insider Monkey
Wedbush Comments on Nuvation Bio’s Q3 Earnings (NYSE:NUVB) - Defense World
Nuvation Bio Positioned for Growth: Buy Rating Affirmed on Strategic Moves and Promising Drug Pipeline - TipRanks
Nuvation Bio Inc Files For Mixed Shelf, Size Not Disclosed -March 06, 2025 at 05:35 pm EST - Marketscreener.com
Nuvation Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Nuvation Bio reports Q4 EPS (15c), two estimates (12c) - TipRanks
Nuvation Bio Inc. SEC 10-K Report - TradingView
Nuvation Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - WICZ
Nuvation Bio Inc (NYSE: NUVB) Stock Is A Good Option To Consider - Stocks Register
Nuvation Bio Enters Supply Agreement With Asymchem Laboratories -March 05, 2025 at 05:14 pm EST - Marketscreener.com
Nuvation Bio scoops US$250M financing to launch promising lung cancer therapeutic - Mugglehead
Nuvation Bio secures $250m for taletrectinib commercialisation - Yahoo Finance
Nuvation Bio (NYSE:NUVB) Given Outperform Rating at Wedbush - Defense World
Nuvation Bio Secures Up to $250 Million in Non-Dilutive Financings from Sagard Healthcare Partners - BioSpace
Nuvation Bio secures up to $250M from Sagard Healthcare Partners; shares rise - MSN
Nuvation Bio Inc Stock (NUVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.05%
1.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):